Diagnostic Imaging Centers (U.S.) — An Investor's Primer

NAICS 2022 code 621512. A general-audience guide for both public-market and private investors. (NAICS = North American Industry Classification System, the U.S. government's standard for grouping businesses.)

1. Overview

A diagnostic imaging center is a freestanding, outpatient facility where a patient — usually on a doctor's referral — gets pictures taken of the inside of their body: an MRI (magnetic resonance imaging, which uses magnets and radio waves), a CT scan (computed tomography, cross-sectional X-rays), an X-ray, an ultrasound, a mammogram, or a PET scan (positron emission tomography, which tracks a radioactive tracer). The images are interpreted by a radiologist, and the report goes back to the referring physician. These centers do not treat the patient; they produce the picture and the read.[4]

This is an outpatient healthcare-services business, not an equipment business. It sits at the intersection of two durable trends: an aging population that needs more imaging, and a decade-long push by insurers and employers to move scans out of expensive hospitals and into cheaper freestanding centers. An identical scan commonly costs 30–150% less in a standalone center than when billed by a hospital.[26] That price gap is the industry's core tailwind.

There are two ways in. Public-market investors have a very narrow menu — two pure-play imaging operators (RadNet and the newly public Lumexa), a tiny MRI-maker, and indirect exposure through diversified hospital companies, scanner manufacturers, and health insurers. Private investors face a much richer field: the industry is highly fragmented, dominated by private-equity-backed chains and hospital joint ventures, and individual centers are an active market for direct ownership, roll-ups, private credit, and real estate. The central question either way is whether an operator can keep expensive scanners and clinical staff productive while securing favorable payer contracts and physician referrals.

2. What it is, and how it's structured

Scope. NAICS 621512 covers establishments primarily engaged in producing images of patients — MRI, CT, X-ray, ultrasound, mammography, and nuclear/PET — in a standalone outpatient setting.[4] A typical center offers routine imaging (X-ray, ultrasound, mammography, bone-density) and advanced imaging (MRI, CT, PET, nuclear medicine), plus related services such as contrast administration and image-guided procedures.

The business usually separates the facility's technical service from the radiologist's professional interpretation: the center supplies the site, scanner, technologists, scheduling, and billing, while an employed or contracted radiology group reads the images. Large platforms may layer on radiology management, teleradiology, software, and artificial-intelligence (AI) tools.[10][12]

What it excludes (this is where the official numbers get narrow):

• Hospitals and their outpatient imaging departments — classified under General Medical and Surgical Hospitals (NAICS 622110). A large share of all U.S. imaging happens here.
• Imaging done inside a doctor's office (e.g., an orthopedist's in-office X-ray, a cardiologist's echocardiogram) — Offices of Physicians (NAICS 621111).
• Medical laboratories that analyze blood, tissue, and other specimens — NAICS 621511, the sibling code. Labs analyze samples; imaging centers produce pictures.[4]
• Broader outpatient-care centers — NAICS 621498.
• Manufacturers of the scanners themselves (GE HealthCare, Siemens Healthineers, Philips, Canon) — equipment makers, not service providers.

Ownership mix. Freestanding imaging is a patchwork of owner types: (1) large multi-state operators, mostly private-equity (PE)-backed; (2) hospital and health-system joint ventures (JVs), an increasingly popular model where a health system partners with an operator to run lower-cost outpatient sites; (3) radiologist-group-owned centers, once the norm and now increasingly rare; and (4) single-modality independents (a lone MRI or mammography shop). Wholly independent, radiologist-owned chains have dwindled to a handful.[17] The supplied federal statistics do not provide an ownership breakdown.

3. How big it is

Per the federal government's own business statistics for NAICS 621512:

(CBP = County Business Patterns; SBA = Small Business Administration.) Independent market research puts the freestanding diagnostic-imaging-center market at about $26 billion across roughly 6,900 facilities[8] — closely matching the federal receipts and establishment counts, a useful cross-check.

The industry is genuinely fragmented. The four largest firms take just 12.9% of revenue; the top 8 take 18.9%, the top 20 about 30.0%, and the top 50 only 43.9% — so more than half of all revenue sits outside the 50 biggest companies.[2] The Herfindahl-Hirschman Index (HHI, a standard concentration measure where 10,000 is a monopoly) is a very low 76.1.[2] That said, local markets can be far more concentrated than the national picture, because patients and referring physicians choose among nearby centers.

Undercount caveat — important here. These figures describe only freestanding centers, and they capture only employer establishments. Two gaps follow. First, they deliberately exclude imaging performed in hospital outpatient departments and physician offices, which is why the broader "U.S. diagnostic imaging services" market — counting all settings — is measured in the hundreds of billions of dollars.[7] NAICS 621512 is the outpatient-center slice of a much larger imaging economy, not the whole thing. Second, CBP excludes the self-employed and most government workers, and the Economic Census targets establishments with paid employees and excludes most government-owned ones.[5][6] So the federal figures can undercount owner-operated practices, very small operators, and public, Veterans Affairs, academic, or municipal imaging departments. No nonemployer adjustment is in our data, so none is estimated here. The supplied statistics also contain no scan volume, utilization, modality mix, payer mix, or margin figures — those come from company and industry sources below.

4. The investable universe

Public equity options are strikingly thin for an industry this size — a direct consequence of the fragmentation above and of private equity having absorbed most scaled operators.

Publicly traded — direct operators:

Publicly traded — diversified/indirect exposure:

Beyond these, exposure is indirect: scanner manufacturers (GE HealthCare, Siemens Healthineers, Philips, Canon), radiology-software firms, healthcare REITs (real estate investment trusts), or the payers on the other side of the reimbursement table — different businesses that do not carry an imaging center's operating economics.

Major private and PE-backed owners (where most of the industry actually lives):

The takeaway: this is overwhelmingly a private investing story. If you want to own imaging centers, the realistic routes are private equity, hospital-JV structures, private credit, or direct/roll-up ownership — not the stock market. No complete national ownership directory exists in our data.

5. How the money works

An imaging center is a high-fixed-cost, volume-driven business. It buys or leases a scanner (an MRI or PET/CT machine can run into the low millions of dollars), staffs it, houses it, and then needs to run as many scans through it as possible. Because most costs are fixed, profit is overwhelmingly a function of throughput and utilization — scans per machine per day, uptime, and hours of operation. A slow scanner is lost capacity that can't be recovered later; every additional scan on an already-installed machine is highly profitable.

Revenue ≈ exam volume × net revenue per exam (plus professional, management, and other fees). Both levers matter:

• Volume is driven by physician referrals, screening programs, disease prevalence, appointment availability, and the payer steerage described in Section 6.
• Revenue per scan is a blend of modality mix and payer mix.

Modality mix. A basic X-ray or ultrasound pays a little; an MRI, CT, or PET/CT ("advanced imaging") pays far more, though it requires costlier equipment and specialized labor. Operators actively push their mix toward advanced imaging — RadNet, for example, reports "same-center advanced imaging" growth as a key metric, because shifting a center toward MRI/CT/PET raises revenue per patient without adding a patient.[10] Multi-modality centers also spread fixed costs across more procedures and reduce dependence on any single reimbursement category.

Payer mix. The same scan pays very differently depending on who foots the bill: commercial insurance pays the most, Medicare less, and Medicaid least. A scan has two billable pieces — the technical component (facility, equipment, technologist) and the professional component (the radiologist's read). Freestanding centers typically own the technical side and either employ radiologists or contract the professional read. As a company-specific illustration (not an industry average), Lumexa reported that commercial payers were 58% of its 2025 revenue and government payers 29%.[12] In some markets (notably California, RadNet's home base), operators also take capitation — a fixed per-member-per-month fee from a health plan to cover a population's imaging — which trades fee-for-service upside for predictable volume.

Margins and leverage. Scaled operators run mid-teens consolidated EBITDA margins (earnings before interest, taxes, depreciation, and amortization); RadNet's 2025 adjusted EBITDA of $300.2M on $2.04B revenue is about 15%,[9] with the core imaging segment higher. Because the model is capital-intensive, it is often financed with debt — which magnifies returns in good times and becomes dangerous when volumes or reimbursement dip. Akumin's 2023 Chapter 11 bankruptcy, which wiped out roughly $470 million of debt and handed the company to a lender, is the cautionary example of over-leverage.[22]

A newer profit lever is software and AI. RadNet's DeepHealth digital-health arm — selling AI-powered reading, workflow, and detection tools — generated $92.7 million in 2025 (up 41%) and is its fastest-growing segment.[9] AI both raises throughput (radiologists read faster) and adds a higher-margin software revenue stream on top of scanning. For diligence, the metrics that matter are same-center volume, revenue per scan, modality mix, equipment utilization, labor cost per study, center-level EBITDA, and operating cash flow after maintenance capital spending.

6. What drives demand

• Aging demographics. The U.S. population aged 65 and older reached 61.2 million — 18.0% of the population — in 2024, and that cohort is the heaviest user of MRI, CT, and ultrasound.[36] As it grows, imaging volume grows with it.
• Chronic disease. Rising rates of cancer, cardiovascular disease, and musculoskeletal conditions all generate scans for diagnosis and monitoring.[39]
• Screening expansion. Broadening guidelines pull healthy people into imaging on a recurring schedule: the U.S. Preventive Services Task Force (USPSTF) recommends biennial mammography for women aged 40–74[37] and annual low-dose CT for adults 50–80 with a qualifying smoking history.[38]
• Site-of-service migration. The industry's single biggest structural tailwind. Because a freestanding center's scan costs a fraction of the hospital's for identical technology, insurers and employers actively steer patients to lower-cost centers, and some plans now require it.[26] Every scan that moves from a hospital outpatient department to a freestanding center is a volume gain for this industry.
• AI and automation. Faster reads and automated triage expand how much a fixed base of scanners and radiologists can handle, converting backlogs into revenue.[9] The near-term benefit is operational efficiency more than an automatic jump in demand.
• Referral density. Centers near high-volume physician groups, hospitals, orthopedic and cancer programs, and primary-care networks have the best odds of sustaining utilization.

7. Regulation

Imaging is one of the more heavily regulated corners of outpatient health care.

• Reimbursement rules (CMS). Medicare sets prices through the annual Medicare Physician Fee Schedule (MPFS). For 2025, the Centers for Medicare & Medicaid Services (CMS) cut the conversion factor — the dollar multiplier applied to every service — by 2.83%, continuing a trend that has trimmed the schedule by roughly 10% over a decade.[27] Because Medicare rates anchor many commercial contracts, these cuts squeeze the whole industry.
• Medicare enrollment (IDTF). A non-hospital, non-physician-office imaging provider that bills Medicare directly is an Independent Diagnostic Testing Facility (IDTF) and must meet federal facility, supervision, and enrollment standards.[31]
• Advanced-imaging accreditation. Under the Medicare Improvements for Patients and Providers Act (MIPPA), a freestanding center must be accredited — by the American College of Radiology (ACR), the Intersocietal Accreditation Commission, or The Joint Commission — to be paid for the technical component of advanced imaging (MRI, CT, nuclear, PET).[28][29]
• Mammography (FDA/MQSA). The Mammography Quality Standards Act (MQSA) requires every mammography facility to be certified by the Food and Drug Administration (FDA), with accreditation, personnel standards, quality control, and periodic inspection; operating without certification is illegal.[30]
• Radiation and nuclear medicine. The Nuclear Regulatory Commission (NRC) or an Agreement State regulates the radioactive materials used in nuclear medicine and PET; states also regulate radiation-producing equipment and technologist licensing.[32]
• Referral and ownership rules. The federal Stark Law (physician self-referral) and Anti-Kickback Statute restrict referrals to facilities in which a physician has a financial interest and certain compensation arrangements. State corporate-practice-of-medicine and fee-splitting rules can require clinical control to stay with physicians, often producing management-services-organization structures.[33]
• Privacy and cybersecurity. The Health Insurance Portability and Accountability Act (HIPAA) Security Rule mandates safeguards for electronic protected health information.[34]
• Utilization controls. CMS built an appropriate-use-criteria (AUC) framework for advanced imaging, then paused implementation for reevaluation; prior authorization and medical-necessity review remain live volume risks.[35]
• Certificate of Need (CON). In many states an operator must get state approval before buying a new scanner or opening a center — limiting supply (and protecting incumbents). State facility licensing and local zoning also affect the cost and speed of expansion.

8. Competitive dynamics and consolidation

Competition is local even when ownership is national. Centers differentiate on location, parking, hours, and appointment speed; referral relationships; modality breadth and equipment quality; radiologist specialization and report turnaround; payer-network participation and price; and billing and digital experience. Because a scan is fairly commoditized, the winners are those who can fill their machines cheaply and negotiate favorable rates — both of which favor scale.

The defining story is consolidation on top of a fragmented base. With ~6,900 facilities and the top 8 firms holding under 19% of revenue,[2] there is a long runway for roll-ups, and two acquirers are running down it:

1. Private equity, the most aggressive consolidator; deal activity stayed steady through 2025 with a dozen-plus imaging transactions. By the end of 2023, roughly 12% of all U.S. radiologists were employed by PE-backed groups, up from about 1% a decade earlier.[24]
2. Hospitals and health systems, increasingly via joint ventures with operators. Rather than build outpatient centers themselves, systems partner with a RadNet or an OIA — contributing referrals, brand, capital, and payer relationships, while the operator brings equipment procurement, staffing, and revenue-cycle management. RadNet alone manages more than two dozen such hospital/health-system JVs.[11]

Consolidation has a documented pricing effect: one analysis found negotiated commercial prices for radiology services were about 16% higher for PE-affiliated radiologists and 43% higher for hospital-employed radiologists than for independents — scale translating into payer-negotiating power.[23] The national market is fragmented, but mergers can still raise antitrust concerns locally; the Federal Trade Commission (FTC) has flagged mergers among imaging and outpatient facilities as an area warranting competitive review.[25]

9. Risks

• Reimbursement pressure. Steady annual erosion of the Medicare fee schedule, plus commercial and Medicare Advantage pushback on rates, network narrowing, and coverage changes, directly compress revenue per scan.[27]
• Referral and utilization risk. Volume depends on physicians and payers; prior authorization and benefit-management programs deny or delay scans and hold down volume.[35]
• Labor shortages. Radiologists, MRI/CT technologists, and sonographers are expensive and hard to replace; radiologist reading capacity is a real throughput bottleneck. The Bureau of Labor Statistics (BLS) projects radiologic and MRI technologist employment to grow 5% from 2024 to 2034, with roughly 15,400 openings a year.[40]
• Capital intensity and technology obsolescence. Scanners require heavy investment, maintenance, and periodic replacement; new systems can strand older equipment before it is fully depreciated, and debt or leases magnify the pain of weak utilization.
• Leverage. The debt-financed roll-up model is fragile when volumes wobble — Akumin's bankruptcy is the object lesson.[22]
• Volume sensitivity. Imaging is somewhat discretionary and schedule-driven; weather, economic softness, or high patient cost-sharing can dent volumes (RadNet cited a ~$22 million weather-driven revenue loss in early 2025).[9]
• Clinical and compliance exposure. Radiation events, contrast reactions, missed diagnoses, malpractice claims, MQSA failures, billing violations, and cyberattacks all carry financial and reputational risk.
• Disclosure risk. Private platforms — most of the industry — disclose far less about payer rates, center margins, debt, related-party arrangements, and clinical outcomes than public companies.
• Policy wildcard — site-neutral payment. Proposals to extend Medicare's site-neutral rates to imaging would equalize what Medicare pays across settings.[41] That cuts hospital rates and, on balance, favors freestanding centers competitively — but it also signals a broader appetite to push imaging prices down everywhere, a two-edged sword.

10. How to invest, and the outlook

Public-market route. The practical options are narrow. RadNet (RDNT) and the newly public Lumexa (LMRI) are the clearest direct exposure to center utilization, payer rates, staffing, capital spending, and acquisitions — with RadNet carrying an added software/AI growth kicker in DeepHealth. Fonar (FONR) is a micro-cap hybrid (scanner-maker plus a handful of Florida centers) that was pursuing a take-private deal in 2026. HCA and THC offer broad hospital exposure with imaging embedded but not separately disclosed. Beyond these, exposure is indirect: scanner manufacturers, radiology software, healthcare real estate, or payers. Reserve any judgment on valuation for your own diligence — the point here is that public breadth is thin.

Private route. This is where the industry mainly is. Options span PE funds specializing in healthcare services, direct ownership or roll-up of independent centers (the SBA's $19 million receipts threshold[3] shows how small a typical target is), hospital-JV structures, private credit, and the real estate underneath the centers. The fragmentation that frustrates stock-pickers is exactly what creates the private opportunity: thousands of sub-scale centers, an aging owner base, and two well-capitalized classes of buyers (PE and hospitals) providing exits. Underwrite the individual market, not just the national growth story: scans per machine per hour, same-center volume growth, referral and payer concentration, denial/collection trends, scanner age and maintenance capital, radiologist/technologist contract durability, leases and JV waterfalls, accreditation status, and integration risk.

Near-term drivers to watch: the pace of site-of-service migration from hospitals; the annual Medicare fee-schedule outcome and any move on site-neutral payment; the shift of center mix toward higher-value advanced imaging; adoption and monetization of AI (throughput plus software revenue); the supply of radiologists and technologists; and the continued flow of PE and hospital-JV consolidation. RadNet's own 2026 guidance — mid-to-high-teens revenue growth and 45–55% growth in its digital-health segment[9] — reflects how a scaled operator expects those forces to net out: steady demand, gradual reimbursement pressure, and technology as the margin story on top.

Editorial judgment. The outlook is constructive but execution-dependent. Aging, screening, and the outpatient shift should support long-term demand, but more scans alone will not guarantee returns — reimbursement cuts, labor inflation, idle equipment, excessive leverage, and weak collections can absorb much of the growth. The most investable model is not simply "buy imaging," but back operators that combine local density, multi-modality capacity, clinical credibility, payer access, and reliable cash conversion — whoever can run the most scans through the most machines at the best-negotiated rates.

---

Sources

1. U.S. Census Bureau, County Business Patterns, NAICS 621512 (2023). Establishments, employment, payroll. https://data.census.gov/table/CBP2023.CB2300CBP
2. U.S. Census Bureau, 2022 Economic Census — Concentration of Largest Firms & Receipts, NAICS 621512. Firm count, receipts, CR4/CR8/CR20/CR50, HHI. https://data.census.gov/table/EC2200SIZECONCEN
3. U.S. Small Business Administration, Table of Small Business Size Standards (2023). https://www.sba.gov/document/support-table-size-standards
4. U.S. Census Bureau, 2022 NAICS: 621512 Diagnostic Imaging Centers (definition and cross-references to 621511, 621111, 621498, 622110). https://www.census.gov/naics/?details=621512&input=621512&year=2022
5. U.S. Census Bureau, County Business Patterns Methodology (coverage/exclusions). https://www.census.gov/programs-surveys/cbp/technical-documentation/methodology.html
6. U.S. Census Bureau, 2022 Economic Census Methodology. https://www.census.gov/programs-surveys/economic-census/year/2022/technical-documentation/methodology.html
7. Fortune Business Insights, "U.S. Diagnostic Imaging Services Market Size & Growth" (2025). https://www.fortunebusinessinsights.com/u-s-diagnostic-imaging-services-market-106552
8. GlobeNewswire / Research and Markets, "U.S. Diagnostic Imaging Centers Industry Report 2025: $26 Billion, ~6,900 Facilities, Fragmented" (2026). https://www.globenewswire.com/news-release/2026/04/08/3270253/0/en/U-S-Diagnostic-Imaging-Centers-Industry-Report-2025-Analysis-of-the-26-Billion-Technology-driven-and-Fragmented-Market-with-6-900-Facilities.html
9. RadNet, Inc., "RadNet Reports Fourth Quarter 2025 Results, Record Revenue and Adjusted EBITDA, and 2026 Guidance" (2026). https://www.globenewswire.com/news-release/2026/03/02/3247156/10985/en/RadNet-Reports-Fourth-Quarter-2025-Results-Including-Record-Revenue-and-Adjusted-EBITDA-and-Releases-2026-Financial-Guidance.html
10. RadNet, Inc., 2025 Form 10-K (center count, nine states, business segments). https://www.sec.gov/Archives/edgar/data/790526/000162828026013337/rdnt-20251231.htm
11. RadNet, Inc., corporate site — annual procedures and hospital/health-system joint ventures (2026). https://www.radnet.com/
12. Lumexa Imaging Holdings, Inc. (formerly US Radiology Specialists), 2025 Annual Report (center count, consolidated vs. equity-method sites, payer mix). https://ir.lumexaimaging.com/
13. StockTitan / SEC, "FONAR Corporation (FONR) Overview" and Form PREM14A (take-private) (2026). https://www.stocktitan.net/overview/FONR/
14. StockAnalysis.com, "RadNet (RDNT) Market Cap" (2026). https://stockanalysis.com/stocks/rdnt/market-cap/
15. HCA Healthcare, Inc., 2025 Form 10-K. https://www.sec.gov/Archives/edgar/data/860730/000119312526044769/hca-20251231.htm
16. Tenet Healthcare Corporation, 2025 Form 10-K (50 hospitals, 132 outpatient facilities). https://www.sec.gov/Archives/edgar/data/70318/000007031826000012/thc-20251231.htm
17. Radiology Business, "The 20 Largest Outpatient-imaging Center Chains: Consolidation Continues, Hospital Alignment Takes Root." https://radiologybusiness.com/topics/medical-practice-management/20-largest-outpatient-imaging-center-chains-consolidation
18. American Securities, "SimonMed" (portfolio: 150+ sites, 10 states). https://www.american-securities.com/en/companies/simonmed
19. RAYUS Radiology, "Hospital Partnerships." https://rayusradiology.com/partners/hospital-partnerships/
20. RAYUS Radiology, "Wellspring Capital-Backed RAYUS Radiology Acquires Diagnostic Centers of America" (2021). https://rayusradiology.com/blog/wellspring-capital-backed-rayus-radiology-acquires-diagnostic-centers-of-america-bolstering-its-growing-nationwide-network/
21. TowerBrook Capital Partners, "Healthcare Portfolio: Solis Mammography" (2025). https://www.towerbrook.com/investments/healthcare/
22. Sidley Austin LLP, "Sidley Represents Stonepeak in Take-Private Transaction of Akumin Through Chapter 11 Process" (2024). https://www.sidley.com/en/newslanding/newsannouncements/2024/02/sidley-represents-stonepeak-in-take-private-transaction-of-akumin
23. Journal of the American College of Radiology, "Association of Private Equity and Hospital Consolidation and Negotiated Prices of Radiologic Services" (2025). https://www.jacr.org/article/S1546-1440(25)00403-X/fulltext
24. Radiology Business, "Private Equity Activity 'Steady' in 2025, with a Dozen-Plus Deals in Diagnostic Imaging" (2026). https://radiologybusiness.com/topics/healthcare-management/healthcare-economics/private-equity-activity-steady-2025-dozen-plus-deals-diagnostic-imaging
25. Federal Trade Commission, "Physician Group and Healthcare Facility Merger Study" (2021). https://www.ftc.gov/enforcement/competition-matters/2021/04/physician-group-healthcare-facility-merger-study
26. One Step Diagnostic / HFMA, "Outpatient Imaging Centers vs. Hospitals: Price Differential" (2026). https://www.onestepdiagnostic.com/outpatient-imaging-centers-vs-hospitals/
27. Radiology Business / Healthcare Administrative Partners, "Medicare Finalizes 2025 Fee Schedule Cut" (conversion factor −2.83%) (2024). https://info.hapusa.com/blog-0/medicare-finalizes-2025-fee-schedule-cut
28. American College of Radiology, "ACR Accreditation" (MIPPA-required for advanced imaging). https://www.acr.org/Accreditation
29. Centers for Medicare & Medicaid Services, "Advanced Diagnostic Imaging Accreditation." https://www.cms.gov/medicare/provider-enrollment-and-certification/medicareprovidersupenroll
30. U.S. Food and Drug Administration, "Mammography Quality Standards Act (MQSA) and MQSA Program." https://www.fda.gov/radiation-emitting-products/mammography-quality-standards-act-mqsa-and-mqsa-program
31. Centers for Medicare & Medicaid Services, "Independent Diagnostic Testing Facility" (MLN909060). https://www.cms.gov/files/document/mln909060-independent-diagnostic-testing-facility.pdf
32. U.S. Nuclear Regulatory Commission, "Medical Uses of Nuclear Materials." https://www.nrc.gov/materials/miau/med-use
33. American Medical Association, "Corporate Practice of Medicine." https://www.ama-assn.org/media/7661/download
34. U.S. Department of Health and Human Services, "The HIPAA Security Rule." https://www.hhs.gov/hipaa/for-professionals/security/index.html
35. Centers for Medicare & Medicaid Services, "Appropriate Use Criteria Program." https://www.cms.gov/medicare/quality/appropriate-use-criteria-program
36. U.S. Census Bureau, "Older Adults Outnumber Children in 11 States and Nearly Half of U.S. Counties" (61.2M / 18.0% aged 65+, 2024) (2025). https://www.census.gov/newsroom/press-releases/2025/older-adults-outnumber-children.html
37. U.S. Preventive Services Task Force, "Breast Cancer: Screening" (2024). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
38. U.S. Preventive Services Task Force, "Lung Cancer: Screening" (2021). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
39. Vizient, "The Growing Demand for Imaging Services: Key Trends Shaping the Future." https://www.vizientinc.com/insights/reports/diagnostic-imaging/the-growing-demand-for-imaging-services-key-trends-shaping-the-future
40. U.S. Bureau of Labor Statistics, "Radiologic and MRI Technologists: Occupational Outlook Handbook" (2025). https://www.bls.gov/ooh/healthcare/radiologic-technologists.htm
41. KFF, "Five Things to Know About Medicare Site-Neutral Payment Reforms" (2025). https://www.kff.org/medicare/five-things-to-know-about-medicare-site-neutral-payment-reforms/